{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:06:03Z","timestamp":1784739963281,"version":"3.55.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.livres.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T12:34:43Z","timestamp":1663590883000},"page":"203-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target"],"prefix":"10.1016","volume":"6","author":[{"given":"Hanqing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2022.09.003_bib1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with non-alcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2022.09.003_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease-a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.livres.2020.02.004","article-title":"Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease","volume":"4","author":"Chen","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2022.09.003_bib5","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.clnu.2021.04.011","article-title":"Beverages and non-alcoholic fatty liver disease (NAFLD): think before you drink","volume":"40","author":"Chhimwal","year":"2021","journal-title":"Clin Nutr."},{"key":"10.1016\/j.livres.2022.09.003_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in non-alcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jhep.2020.09.002","article-title":"A\u00a0new definition for non-alcoholic fatty liver disease","volume":"74","author":"Poniachik","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A\u00a0red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.livres.2022.09.003_bib11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/cas.15250","article-title":"Nanomedicine targets iron metabolism for cancer therapy","volume":"113","author":"Lin","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.livres.2022.09.003_bib12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/liv.14503","article-title":"Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver disease","volume":"40","author":"Eder","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.09.003_bib13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/liv.14096","article-title":"Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease","volume":"39","author":"Buzzetti","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.09.003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101235","article-title":"Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db\/db mouse model with iron overload","volume":"51","author":"Altamura","year":"2021","journal-title":"Mol Metab."},{"key":"10.1016\/j.livres.2022.09.003_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.09.022","article-title":"Iron and redox cycling. Do's and don'ts","volume":"133","author":"Koppenol","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2022.09.003_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172614","article-title":"Iron chelators in obesity therapy - old drugs from a new perspective?","volume":"861","author":"Rodrigues de Morais","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.livres.2022.09.003_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","article-title":"Effects of iron overload on chronic metabolic diseases","volume":"2","author":"Fern\u00e1ndez-Real","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.livres.2022.09.003_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1004967","article-title":"Iron overload in human disease","volume":"366","author":"Fleming","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2022.09.003_bib19","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.livres.2022.09.003_bib20","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-deficiency anemia","volume":"372","author":"Camaschella","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2022.09.003_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2022.09.003_bib22","first-page":"446","article-title":"Macrophages and systemic iron homeostasis","volume":"4","author":"Ganz","year":"2012","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.livres.2022.09.003_bib23","series-title":"Anatomy and Physiology of the Liver","first-page":"161","article-title":"Anesthesia for hepatico-pancreatic-biliary surgery and transplantation","author":"Yang","year":"2021"},{"key":"10.1016\/j.livres.2022.09.003_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep4.1190","article-title":"Hepatic iron concentration correlates with insulin sensitivity in non-alcoholic fatty liver disease","volume":"2","author":"Britton","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2022.09.003_bib25","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.3748\/wjg.v22.i36.8112","article-title":"Iron and non-alcoholic fatty liver disease","volume":"22","author":"Britton","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrd.2016.248","article-title":"Targeting iron metabolism in drug discovery and delivery","volume":"16","author":"Crielaard","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.livres.2022.09.003_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2014.00104","article-title":"Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis","volume":"5","author":"Core","year":"2014","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.livres.2022.09.003_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00109-009-0447-2","article-title":"Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV\/BMP\/SMAD","volume":"87","author":"Casanovas","year":"2009","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.livres.2022.09.003_bib29","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.0409808102","article-title":"Regulation of hepcidin transcription by interleukin-1 and interleukine-6","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2022.09.003_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.freeradbiomed.2021.03.019","article-title":"Black pepper prevents anemia of inflammation by inhibiting hepcidin over-expression through BMP6-SMAD1\/IL6-STAT3 signaling pathway","volume":"168","author":"Banerjee","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2022.09.003_bib31","article-title":"Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice","volume":"295","author":"Poli","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.09.003_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41588-019-0548-y","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"52","author":"Kautz","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.livres.2022.09.003_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","article-title":"SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis","volume":"22","author":"Jenkitkasemwong","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.09.003_bib34","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1073\/pnas.0606424103","article-title":"Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells","volume":"103","author":"Liuzzi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2022.09.003_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/eci.12032","article-title":"Iron homeostasis in the metabolic syndrome","volume":"43","author":"Datz","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.livres.2022.09.003_bib36","doi-asserted-by":"crossref","first-page":"G157","DOI":"10.1152\/ajpgi.00004.2017","article-title":"The liver in regulation of iron homeostasis","volume":"313","author":"Rishi","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.09.003_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/j.gastro.2010.01.023","article-title":"The role of iron in non-alcoholic fatty liver disease: the story continues","volume":"138","author":"Kowdley","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.09.003_bib38","doi-asserted-by":"crossref","first-page":"G117","DOI":"10.1152\/ajpgi.00246.2015","article-title":"Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to non-alcoholic steatohepatitis in genetically obese mice","volume":"310","author":"Handa","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.09.003_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3748\/wjg.v25.i5.521","article-title":"Iron and liver fibrosis: mechanistic and clinical aspects","volume":"25","author":"Mehta","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1499-3872(16)60135-2","article-title":"Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis","volume":"15","author":"Sikorska","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.livres.2022.09.003_bib41","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1002\/jcb.27184","article-title":"Iron metabolism gene expression and prognostic features of hepatocellular carcinoma","volume":"119","author":"Shen","year":"2018","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.livres.2022.09.003_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-011-0234-4","article-title":"Iron metabolism in non-alcoholic fatty liver disease","volume":"14","author":"Nelson","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.livres.2022.09.003_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in non-alcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1055-9965.EPI-21-0754","article-title":"Serum biomarkers of iron status and risk of hepatocellular carcinoma development in patients with non-alcoholic fatty liver disease","volume":"31","author":"Yu","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.livres.2022.09.003_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2174\/1381612826666200130090703","article-title":"Dysmetabolic iron overload in metabolic syndrome","volume":"26","author":"Sachinidis","year":"2020","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.livres.2022.09.003_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.dld.2010.07.006","article-title":"Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases","volume":"43","author":"Fargion","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.livres.2022.09.003_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.livres.2022.09.003_bib48","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.12659\/MSM.896494","article-title":"The role of iron and iron overload in chronic liver disease","volume":"22","author":"Milic","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.livres.2022.09.003_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.2040-4603.2013.tb00494.x","article-title":"Iron homeostasis in the liver","volume":"3","author":"Anderson","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.livres.2022.09.003_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/liv.13513","article-title":"Hepatic iron is the major determinant of serum ferritin in NAFLD patients","volume":"38","author":"Ryan","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.09.003_bib51","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1017\/S0007114516001197","article-title":"Decreased hepatic iron in response to alcohol may contribute to alcohol-induced suppression of hepcidin","volume":"115","author":"Varghese","year":"2016","journal-title":"Br J Nutr"},{"key":"10.1016\/j.livres.2022.09.003_bib52","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.3748\/wjg.v13.i37.4925","article-title":"Role of alcohol in the regulation of iron metabolism","volume":"13","author":"Harrison-Findik","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib53","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4103\/0366-6999.202737","article-title":"Relationship between hepatitis C virus infection and iron overload","volume":"130","author":"Zou","year":"2017","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.livres.2022.09.003_bib54","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1053\/j.gastro.2006.02.060","article-title":"Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein","volume":"130","author":"Furutani","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.09.003_bib55","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17435390.2021.1919329","article-title":"Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in non-alcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload","volume":"15","author":"Zhu","year":"2021","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.livres.2022.09.003_bib56","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.3748\/wjg.v13.i35.4699","article-title":"Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis\/insulin resistance","volume":"13","author":"Kohgo","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib57","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhep.2017.03.012","article-title":"Mice lacking liver-specific \u03b2-catenin develop steatohepatitis and fibrosis after iron overload","volume":"67","author":"Preziosi","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib58","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Non-alcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.09.003_bib59","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Non-alcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2022.09.003_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fchem.2020.00407","article-title":"Rapamycin-loaded mPEG-PLGA nanoparticles ameliorate hepatic steatosis and liver injury in non-alcoholic fatty liver disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.livres.2022.09.003_bib61","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/ijms20092132","article-title":"Iron-induced liver injury: a critical reappraisal","volume":"20","author":"Bloomer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2022.09.003_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1534\/genetics.116.186742","article-title":"Iron overload coordinately promotes ferritin expression and fat accumulation in caenorhabditis elegans","volume":"203","author":"Wang","year":"2016","journal-title":"Genetics"},{"key":"10.1016\/j.livres.2022.09.003_bib63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1665-2681(19)30864-6","article-title":"Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease","volume":"13","author":"Beaton","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib64","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.RA119.009644","article-title":"Lipogenic SREBP-1a\/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms","volume":"294","author":"Xiaoli","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.09.003_bib65","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3748\/wjg.v18.i29.3782","article-title":"Diagnostic and therapeutic implications of the association between ferritin level and severity of non-alcoholic fatty liver disease","volume":"18","author":"Valenti","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib66","article-title":"A\u00a0high-fructose diet in rats induces systemic iron deficiency and hepatic iron overload by an inflammation mechanism","volume":"45","author":"Wang","year":"2021","journal-title":"J\u00a0Food Biochem"},{"key":"10.1016\/j.livres.2022.09.003_bib67","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.510290612","article-title":"Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats","volume":"29","author":"Brunet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/ph11040113","article-title":"Links between iron and lipids: implications in some major human diseases","volume":"11","author":"Rockfield","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.livres.2022.09.003_bib69","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2022.09.003_bib70","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.livres.2022.09.003_bib71","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin resistance in non-alcoholic fatty liver disease","volume":"16","author":"Bugianesi","year":"2010","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.livres.2022.09.003_bib72","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947911","article-title":"Iron overload inhibits late stage autophagic flux leading to insulin resistance","volume":"20","author":"Jahng","year":"2019","journal-title":"EMBO Rep"},{"key":"10.1016\/j.livres.2022.09.003_bib73","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2011.05.008","article-title":"Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target","volume":"55","author":"Dongiovanni","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib74","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.ajpath.2013.02.019","article-title":"Dietary iron overload induces visceral adipose tissue insulin resistance","volume":"182","author":"Dongiovanni","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2022.09.003_bib75","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc14-3082","article-title":"Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes","volume":"38","author":"Fern\u00e1ndez-Real","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.livres.2022.09.003_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.livres.2022.09.003_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15586\/jrenhep.v5i2.110","article-title":"The role of the liver in iron homeostasis and what goes wrong?","volume":"5","author":"Robalino","year":"2021","journal-title":"Journal of Renal and Hepatic Disorders"},{"key":"10.1016\/j.livres.2022.09.003_bib78","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jhep.2018.02.013","article-title":"The role of Kupffer cells in hepatic iron and lipid metabolism","volume":"69","author":"Scott","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib79","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations","volume":"5","author":"Zampino","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib80","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1478-3231.2008.01825.x","article-title":"Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition","volume":"28","author":"Svegliati-Baroni","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.09.003_bib81","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib82","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.03.014","article-title":"Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD","volume":"75","author":"Corradini","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/138955708783498087","article-title":"Importance of iron and iron metabolism in non-alcoholic fatty liver disease","volume":"8","author":"Baptista-Gonzalez","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.livres.2022.09.003_bib84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2008.11.011","article-title":"Iron in NASH, chronic liver diseases and HCC: how much iron is too much?","volume":"50","author":"Pietrangelo","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjms.2017.08.012","article-title":"Iron enhances hepatic fibrogenesis and activates transforming growth factor-\u03b2 signaling in murine hepatic stellate cells","volume":"355","author":"Mehta","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.livres.2022.09.003_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.122588","article-title":"TCDD promotes liver fibrosis through disordering systemic and hepatic iron homeostasis","volume":"395","author":"Li","year":"2020","journal-title":"J\u00a0Hazard Mater"},{"key":"10.1016\/j.livres.2022.09.003_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.102032","article-title":"Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH","volume":"24","author":"Kanamori","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.livres.2022.09.003_bib88","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/JLB.3A0318-108R","article-title":"Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis","volume":"105","author":"Handa","year":"2019","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.livres.2022.09.003_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114748","article-title":"Iron chelation by deferasirox confers protection against concanavalin A-induced liver fibrosis: a mechanistic approach","volume":"382","author":"Adel","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.livres.2022.09.003_bib90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.23736\/S0391-1977.16.02565-7","article-title":"Iron overload and non-alcoholic fatty liver disease","volume":"42","author":"Datz","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.livres.2022.09.003_bib91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5604\/16652681.1226818","article-title":"Differences in hepatic expression of iron, inflammation and stress-related genes in patients with non-alcoholic steatohepatitis","volume":"16","author":"Handa","year":"2017","journal-title":"Ann Hepatol"},{"issue":"Supplement_1","key":"10.1016\/j.livres.2022.09.003_bib92","first-page":"114","article-title":"Possible protective role of deferoxamine in ameliorating osteoporosis in a rat model of liver cirrhosis via iron metabolism regulation","author":"Helmy","year":"2021","journal-title":"QJM: Int J Med"},{"key":"10.1016\/j.livres.2022.09.003_bib93","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20190257","article-title":"Iron overload and liver cancer","volume":"216","author":"Molina-S\u00e1nchez","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.livres.2022.09.003_bib94","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cld.350","article-title":"Role of iron in hepatocellular carcinoma","volume":"3","author":"Fargion","year":"2014","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.livres.2022.09.003_bib95","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"American association for the study of liver diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib96","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1084\/jem.20180900","article-title":"Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis","volume":"216","author":"Muto","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.livres.2022.09.003_bib97","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2018.07.006","article-title":"The role of iron in hepatic inflammation and hepatocellular carcinoma","volume":"133","author":"Miyanishi","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2022.09.003_bib98","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jca.21867","article-title":"A\u00a0predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with na\u00efve hereditary hemochromatosis","volume":"36","author":"Rombout-Sestrienkova","year":"2021","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.livres.2022.09.003_bib99","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hep.27662","article-title":"The impact of phlebotomy in non-alcoholic fatty liver disease: a prospective, randomized, controlled trial","volume":"61","author":"Adams","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/apt.12255","article-title":"Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease","volume":"37","author":"Beaton","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2022.09.003_bib101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2277-9175.200787","article-title":"Effects of phlebotomy on liver enzymes and histology of patients with non-alcoholic fatty liver disease","volume":"6","author":"Khodadoostan","year":"2017","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.livres.2022.09.003_bib102","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/1055-9965.EPI-08-0725","article-title":"Iron overload is associated with hepatic oxidative damage to DNA in non-alcoholic steatohepatitis","volume":"18","author":"Fujita","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.livres.2022.09.003_bib103","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/gast.2002.32403","article-title":"Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of non-alcoholic fatty liver disease","volume":"122","author":"Facchini","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.09.003_bib104","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21260","article-title":"Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases","volume":"44","author":"Facchini","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.09.003_bib105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/apt.15173","article-title":"Review article: iron disturbances in chronic liver diseases other than haemochromatosis- pathogenic, prognostic, and therapeutic implications","volume":"49","author":"Czaja","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1(Suppl 1","key":"10.1016\/j.livres.2022.09.003_bib106","first-page":"s75","article-title":"Current applications of therapeutic phlebotomy","volume":"12","author":"Assi","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.livres.2022.09.003_bib107","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/bjh.14712","article-title":"The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major","volume":"178","author":"Di Maggio","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.livres.2022.09.003_bib108","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41467-019-13143-z","article-title":"Renal clearable nanochelators for iron overload therapy","volume":"10","author":"Kang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2022.09.003_bib109","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nyas.13174","article-title":"Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob\/ob mice","volume":"1375","author":"Xue","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.livres.2022.09.003_bib110","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1074\/jbc.M409897200","article-title":"Fluctuations of intracellular iron modulate elastin production","volume":"280","author":"Bunda","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.09.003_bib111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00535-007-2020-5","article-title":"The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis","volume":"42","author":"Jin","year":"2007","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.livres.2022.09.003_bib112","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1440-1681.12591","article-title":"Deferoxamine alleviates liver fibrosis induced by CCl4 in rats","volume":"43","author":"Mohammed","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.livres.2022.09.003_bib113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/pharmaceutics12030238","article-title":"Formulation and in-vitro characterization of chitosan-nanoparticles loaded with the iron chelator deferoxamine mesylate (DFO)","volume":"12","author":"Lazaridou","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.livres.2022.09.003_bib114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-015-0039-1","article-title":"Polymeric nanocarriers for the treatment of systemic iron overload","volume":"3","author":"Hamilton","year":"2015","journal-title":"Mol Cell Ther"},{"key":"10.1016\/j.livres.2022.09.003_bib115","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1021\/acsabm.9b00879","article-title":"Doxorubicin-metal coordinated micellar nanoparticles for intracellular codelivery and chemo\/chemodynamic therapy in\u00a0vitro","volume":"2","author":"Ruan","year":"2019","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.livres.2022.09.003_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120642","article-title":"D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy","volume":"269","author":"Du","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.livres.2022.09.003_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006007","article-title":"Development of a cancer vaccine using in\u00a0vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.livres.2022.09.003_bib118","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1021\/acs.nanolett.8b02428","article-title":"Polymeric nanoparticles enhance the ability of deferoxamine to deplete hepatic and systemic iron","volume":"18","author":"Guo","year":"2018","journal-title":"Nano Lett"},{"key":"10.1016\/j.livres.2022.09.003_bib119","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2217\/nnm-2020-0038","article-title":"Combating iron overload: a case for deferoxamine-based nanochelators","volume":"15","author":"Jones","year":"2020","journal-title":"Nanomed"},{"key":"10.1016\/j.livres.2022.09.003_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.592294","article-title":"PEGylation of deferoxamine for improving the stability, cytotoxicity, and iron-overload in an experimental stroke model in rats","volume":"8","author":"Xu","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.livres.2022.09.003_bib121","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cjce.23048","article-title":"Synthesis of nano-niosomal deferoxamine and evaluation of its functional characteristics to apply as an iron-chelating agent","volume":"96","author":"Marzban","year":"2018","journal-title":"Can J Chem Eng"},{"key":"10.1016\/j.livres.2022.09.003_bib122","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/acsnano.0c01083","article-title":"Reactive oxygen species-triggered dissociation of a polyrotaxane-based nanochelator for enhanced clearance of systemic and hepatic iron","volume":"15","author":"Liu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.livres.2022.09.003_bib123","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.livres.2022.09.003_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174319","article-title":"Ferroptosis as a new therapeutic opportunity for nonviral liver disease","volume":"908","author":"Jia","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.livres.2022.09.003_bib125","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15163","article-title":"Ferroptosis and metabolic dysfunction-associated fatty liver disease: is there a link?","author":"Feng","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.09.003_bib126","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/biomedicines9111660","article-title":"Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2022.09.003_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174351","article-title":"Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4","volume":"908","author":"Zhu","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.livres.2022.09.003_bib128","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2020.06.016","article-title":"MAFLD criteria overlooks a number of patients with severe steatosis: is it clinically relevant?","volume":"73","author":"Huang","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.09.003_bib129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bl\u00fcher","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.livres.2022.09.003_bib130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1530\/EC-18-0054","article-title":"Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob\/ob mice","volume":"7","author":"Yan","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.livres.2022.09.003_bib131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2337\/db13-0213","article-title":"Obesity alters adipose tissue macrophage iron content and tissue iron distribution","volume":"63","author":"Orr","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.livres.2022.09.003_bib132","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/dc13-1602","article-title":"Insulin resistance modulates iron-related proteins in adipose tissue","volume":"37","author":"Moreno-Navarrete","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.livres.2022.09.003_bib133","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review","volume":"44","author":"Hill-Briggs","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.livres.2022.09.003_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2022.09.003_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/516740","article-title":"The utility of iron chelators in the management of inflammatory disorders","volume":"2015","author":"Lehmann","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.livres.2022.09.003_bib136","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12011-018-1446-3","article-title":"Dietary iron modulates glucose and lipid homeostasis in diabetic mice","volume":"189","author":"Ma","year":"2019","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.livres.2022.09.003_bib137","article-title":"Management of iron overload in resource poor nations: a systematic review of phlebotomy and natural chelators","author":"Orisakwe","year":"2020","journal-title":"J\u00a0Toxicol"},{"key":"10.1016\/j.livres.2022.09.003_bib138","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17435390.2021.1919329","article-title":"Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in non-alcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload","volume":"15","author":"Zhu","year":"2021","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.livres.2022.09.003_bib139","article-title":"Gold nanoparticles modified with polyethyleneimine disturbed the activity of drug-metabolic enzymes and induced inflammation-mediated liver injury in mice","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:46:48Z","timestamp":1762872408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568422000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2542568422000459"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2022.09.003","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}